Mission Driven: Education, Research, Patient Care, and Community Partnership
Looking Back, Moving Forward: Duke University School of Medicine 2024 Year in Review
From pursuing climate change research to enhancing the partnership with the Veteran's Administration, and advancing the groundbreaking FDA-approved drug for low-grade gliomas developed by the team at the Preston Robert Tisch Brain Tumor Center, the achievements at the Duke University School of Medicine in 2024 have been remarkable. This short video highlights these and other milestones.
Dr. Shelley Hwang - Surgical Oncologist, Mountain Climber
Shelley Hwang, MD, a surgical oncologist at Duke Cancer Institute, recently unveiled groundbreaking results from the COMET study, which suggests a transformative approach for treating early stage breast cancer (DCIS) through watchful waiting and monitoring as a alternative to surgery.
A History of Excellence and a Future of Promise
Since its founding, the Duke University School of Medicine has been mission-driven in its focus to transform education, research, patient care, and community partnership. Today –100 years after Duke University's creation – the School of Medicine stands as one of the world’s preeminent medical schools, pioneering new treatments for once-fatal diseases, innovating its medical curriculum to meet the needs of an ever-changing world, and remaining deeply committed to serving the community through partnerships with local organizations and global initiatives.
